Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Addus HomeCare | 2,165 | 2023q1 | |||||||||
Amedisys | 3,194 | 2024q2 | |||||||||
Catalent | 0 | 2024 | |||||||||
Charles River Laboratorie... | 11,645 | 2023 | |||||||||
Chemed | 9,697 | 2022 | |||||||||
Clover Health Investments | 400 | 2023q3 | |||||||||
Doximity | 5,156 | 2024q3 | |||||||||
Health Catalyst | 457 | 2023 | |||||||||
IQVIA Holdings | 32,852 | 2023q3 | |||||||||
Laboratory Corp of Americ... | 19,418 | 2023 | |||||||||
Medifast | 770 | 2023q3 | |||||||||
Medpace Holdings | 11,922 | 2023q2 | |||||||||
ModivCare | 301 | 2022 | |||||||||
NeoGenomics | 1,725 | 2023q3 | |||||||||
Pediatrix Medical Group | 0 | 2024q2 | |||||||||
Progyny | 3,594 | 2023 | |||||||||
Quest Diagnostics | 14,107 | 2023q3 | |||||||||
Teladoc Health | 2,168 | 2023 | |||||||||
The Pennant Group | 349 | 2023q3 | |||||||||
ΠΡΡΠ³Π΅Π½ | 84 | 2024q2 |